UNCY fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Unicycive Therapeutics, Inc. engages in the development of treatment for kidney diseases. Its products include UNI-494, Renazorb, and UNI-220. The company was founded by Shalabh Gupta on August 18, 2016 and is headquartered in Los Altos, CA.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
No dividends
UNCY has never paid dividends and has no current plans to do so.
Financial health
Financial position and solvency of the company